HNTs |
Anti-câncer |
[23[23] SHUTAVA, T. G., et al, "Spherical and tubule nanocarries for sustained drug release", Current opinion in pharmacoly, v. 18, pp. 141-148, 2014.] |
Ibuprofeno |
[24[24] TAN, D., et al, "Loading and in vitro release of ibuprofen in tubular halloysite", Applied Clay science, v. 96, n.11, pp. 1316-1329, 2013.] |
Resveratrol |
[25[22] PASBAKHSH, P., et al, "Characterisation of properties of various halloysites relevante to their use as nanotubes and microfibre fillers", Applied Clay science, v. 74, pp. 47-57, 2013.] |
Tetraciclina |
[26[26] QI, R., et al, "Antibacterial activity of antibiotic-loaded electrospun halloysite/poly(lactic-co-glycolic acid) composite nanofibers", International fórum on biomedical textile material, proceedings, pp. 21-25, 2011.] |
Benzitriazol |
[27[27] ABDULLAYEV, E., LVOVO, Y., "Halloysite clay nanotubes as a ceramic 'skeleton' for functional biopolymer composites with sustained drug release", Journal of materials chemistry B, v.1, n. 23, pp. 2894-2903, 2013.] |
Dexametasona |
[28[28] VEERABADRAN, N. G., et al, "Organized shells on clay nanotubes for controlled release of macromolecules", Macromolecular rapid communications, v. 30, n.2, pp. 99-103, 2009.] |
Mesalazina |
[29[29] VISERAS, M. T., et al, "Equilibrium and kinetics of 5-aminosalicylic acid adsorpotion by halloysite", Microporous and mesoporous materials, v. 108, n.1, pp. 112-116, fev. 2008.] |
Dexametasona, Furosemida e Nefedipina |
[30[30] VEERABADRAN, N. G., et al, "Clay nanotubes for encapsulation and sustained release of drugs", Nano, v. 2, n. 2, pp. 115-120, 2007.] |
Dialtizem |
[31[31] BYRNE, R. S., DEASY, P. B., "Use of porous aluminosilicate pellets for drug delivery", Journal of microencapsulation, v. 22, n. 4, 2005.] |
Haloisita modificada com 3- aminopropiltrietoxissilano |
Ibuprofeno |
[32[32] TAN, D., et al, "Loading and in vitro release of ibuprofen in tubular halloysite", Applied clay science, v. 96, pp. 50-55, 2014.] |
Adesivo modificado de HNTs para uso odontológico |
Doxiciclina |
[33[33] FEITOSA, S.A., et al, "Doxycycline-encapsulated nanotube-modified dentin adhesives", Journal of dental research, v. 93, n.12, pp. 1270-1276, 2014.] |
HNTs modificado com sal de triazol |
Curcumina |
[34[34] RIELA, S., et al, "Development and characterization of co-loaded curcumin/triazole-halloysite systems and evaluation of their potential anticancer activity", International journal of pharmaceutics, v.475, n.1, p. 613-623, 2014.] |
Compósito de HNTs e materiais biocompatíveis (hialuronato de sódio com polimetacrilato de hidroxietil) para formação de hidrogel |
5- fluoracila (5-FU) |
[35[35] RAO, K. M., et al, "Ph sensitive halloysite-sodium hyaluronate/poly(hydroxyethyl methacrylate) nanocomposites for colon cancer drug delivery", Applied clay science, v. 97, pp. 33-42, 2014.] |
HNTs modificado com antisurvivina tRNA |
Fármacos de atividade antitumoral |
[36[36] WU, H., et al, "Multifunctional nanocarrier based on clay nanotubes for efficient intracellular sirna delivery and gene silencing", Journal of biomaterials applications, v.28, n.8, pp. 1180-1189, 2014.] |
HNTs em microesferas porosas |
Dopamina; Lacase |
[37[37] CHAO, C., et al, "Natural nanotube-based biomimetic porous microspheres for significantly enhanced biomolecule immobilization", Acs sustainable chemistry & engineering, v.2, n. 3, pp. 396-403, 2014.] |
HNTs modificado com 3-aminopropiltrietoxsilano |
Aspirina |
[38[38] LUN, H., et al, "Natural halloysite nanotubes modified as an aspirin carrier", RSC advances, v. 4, n. 83, 2014.] |
HNTs modificado com ciclodextrinas (unidas aos nanotubos) |
Curcumina |
[34[34] RIELA, S., et al, "Development and characterization of co-loaded curcumin/triazole-halloysite systems and evaluation of their potential anticancer activity", International journal of pharmaceutics, v.475, n.1, p. 613-623, 2014.] |
HNTs com ativação básica da estrutura |
Ofloxacino |
[39[39] WANG, Q., et al, "Alkali activation of halloysite for adsorption and release of ofloxacin", Applied surface science, v. 287, pp. 54-61, 2013.] |
Compósito de HNTs e poli-ácido lático-co-glicólico (PLGA) |
Tetraciclina |
[40[40] QI, R., et al, "Biocompatibility of electrospun halloysite nanotube-doped poly(lactic-co-glycolic acid) composite nanofibers", Journal of biomaterials science-polymer edition, v. 23, pp. 299-313, 2012., 41[41] QI, R., et al, "et al, "Controlled release and antibacterial activity of antibiotic-loaded electrospun halloysite/poly(lactic-co-glycolic acid) composite nanofibers", Colloids and surfaces b-biointerfaces, v. 10, pp. 148-155, 2013., 42[42] QI, R., et al, "Electrospun poly(lactic-co-glycolicacid)/halloysite nanotube composite nanofibers for drug encapsulation and sustained release", Journal of materials chemistry, v. 20, n. 47, 2010.] |
Nanocompósitos HNTs, grânulos de alginato de sódio e hidroxiapatita para formação de hidrogel |
Diclofenaco de sódio |
[43[43] FAN, L., et al, "et al, "In situ generation of sodium alginate/ hydroxyapatite/ halloysite nanotubes nanocomposite hydrogel beads as drug-controlled release matrices", Journal of materials chemistry, v. 1, n. 45, p. 6261-6270, 2013.] |
Microesferas de quitosana, Fe3O4 e HNTs |
Ofloxacino |
[44[44] WANG, Q., et al, "Spray-dried magnetic chitosan/Fe3O4/ halloysite nanotubes/ofloxacin microspheres for sustained release of ofloxacin", RSC advances, v. 3, n. 45, 2013.] |
DNA-envolto em HNTs |
Doxirrubicina |
[45[45] LEE, Y., et al, "Cellular interactions of doxorubicin-loaded dna-modified halloysite nanotubes", Nanoscale, v.5, n. 18, 2013.] |
HNTs enxertado com ácido fólico e magnetita |
Doxirrubicina |
[46[46] GUO, M., et al, "Halloysite Nanotubes, a Multifunctional nanovehicle for anticancer drug delivery.", Chinese journal of chemistry, v. 30, n. 9, p. 2115-2120, 2012.] |
Compósito de HNTs com polimetilmetacrilato (PMMA) formando cimento ósseo para a substituição de quadril e joelho |
Sulfato de gentamicina |
[47[47] WARD, C., et al, "Halloycite nanocaly for controlled release applications", Nanomaterials for biomedicine, v. 1110, pp. 109-138, 2012.] |
Compósito de HNTs com álcool polivinílico, montmorilonita, metacrilato de polimetila formando filmes |
Tetraciclina |
[48[48] WARD, C. J., et al, "Controlled release of tetracycline-HCl from halloysite-polymer composite films", Journal of nanoscience and nanotechnology, v. 10, n. 10, p. 6641-6649, 2010.] |
Pellets com HNTs e celulose microcristalina |
Fentanil |
[49[49] FORSGREN, J., et al, "Ceramic Drug Delivery Vehicle for Oral Administration of Highly Potent Opioids", Journal of Pharmaceutical Sciences, v. 99, n. 1, p. 219-226, 2010.] |